These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8531342)

  • 1. [Investigations of various animal models for Sjögren's syndrome].
    Hayashi Y
    Nihon Rinsho; 1995 Oct; 53(10):2383-8. PubMed ID: 8531342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
    Haneji N; Hamano H; Yanagi K; Hayashi Y
    J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.
    van Blokland SC; Versnel MA
    Clin Immunol; 2002 May; 103(2):111-24. PubMed ID: 12027416
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
    Hayashi Y; Haneji N; Hamano H; Yanagi K
    Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome.
    Hayashi Y; Haneji N; Hamano H; Yanagi K; Takahashi M; Ishimaru N
    Cell Immunol; 1996 Aug; 171(2):217-25. PubMed ID: 8806790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
    Jabs DA; Enger C; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
    Hayashi Y; Haneji N; Hamano H
    Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains.
    Jabs DA; Prendergast RA
    Invest Ophthalmol Vis Sci; 1988 Sep; 29(9):1437-43. PubMed ID: 3047079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analyses of T cell clonality in mice with autoimmune sialoadenitis].
    Masuko K
    Nihon Rinsho; 1995 Oct; 53(10):2401-6. PubMed ID: 8531345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible etiopathogenic genes of Sjögren's syndrome.
    Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
    Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
    Johnson BC; Morton JI; Trune DR
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.
    Yanagi K; Haneji N; Hamano H; Takahashi M; Higashiyama H; Hayashi Y
    Cell Immunol; 1996 Mar; 168(2):243-50. PubMed ID: 8640871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of cytotoxic autoantibody to lacrimal gland cells in NZB/W mice.
    Ohashi Y; So SK; Minasi PN; Tabbara KF
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):214-9. PubMed ID: 3972503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of caspase cascade on the development of primary Sjögren's syndrome.
    Hayashi Y; Arakaki R; Ishimaru N
    J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressions of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice.
    Hamano H; Saito I; Haneji N; Mitsuhashi Y; Miyasaka N; Hayashi Y
    Eur J Immunol; 1993 Oct; 23(10):2387-91. PubMed ID: 8405038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
    Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
    Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased T cell receptor V beta gene usage during specific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjögren's syndrome.
    Hayashi Y; Hamano H; Haneji N; Ishimaru N; Yanagi K
    Arthritis Rheum; 1995 Aug; 38(8):1077-84. PubMed ID: 7639803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligoclonality of T cells in salivary glands of autoimmune MRL/lpr mice.
    Skarstein K; Holmdahl R; Johannessen AC; Jonsson R
    Immunology; 1994 Apr; 81(4):497-501. PubMed ID: 8039804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
    Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.